课题基金 / 基金详情

Regulation of cellular functions by chaperone-like AAA-ATPases, VCP and NVL

Regulation of cellular functions by chaperone-like AAA-ATPases, VCP and NVL
类伴侣 AAA-ATP 酶、VCP 和 NVL 调节细胞功能
批准号:
15570166
负责人:
NAGAHAMA Masami
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

NAGAHAMA Masami的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
VCP is an AAA-ATPase, which plays critical roles for cellular functions such as endoplasmic reticulum associated degradation(ERAD) and organella biogenesis. SVIP has been identified as a VCP-interacting protein, whose expression causes cell vacuolation by expansion of ER. To clarify a cellular function of SVIP, we first investigated a role of SVIP for ERAD by employing assays in virto and in vivo. The results from both the assays showed that extra amount of SVIP inhibits ERAD and this may be a cause of the ER vacuolation. Next, to identify other protein components involved in the VCP-SVIP complex, yeast two-hybrid screening was performed using entire SVIP as a bait As a result, several cDNAs encoding putative SVIP-associated proteins were obtained.NVL2 is a protein that shows high amino acid similarity with VCP. In contrast to mainly cytosolic distribution of VCP, localization of NVL2 is restricted to the nucleolus, suggesting a specialized role of NVL2 in this nuclear subcompartment. In this research, we showed that NVL2 interacts with a RNA helicase and is involved in biogenesis of 60S ribosomes. Although expression of a dominant-negative mutant of NVL2 did not affect rRNA processing, it caused accumulation of the helicase in a large complex, probably a pre-ribosomal particle. Additionally, mutagenesis studies identified a nucleolar localization signal in NVL2. This signal is required for the binding of NVL2 with ribosomal protein L5,suggesting that NVL2 is recruited to the nucleolus by associating with L5.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1091/mbc.e04-08-0692
发表时间: 2004-10
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [M. Nagahama;Y. Hara;Akihiro Seki;Takeshi Yamazoe;Yumiko Kawate;T. Shinohara;K. Hatsuzawa;K. Tani-K.]
通讯作者: M. Nagahama;Y. Hara;Akihiro Seki;Takeshi Yamazoe;Yumiko Kawate;T. Shinohara;K. Hatsuzawa;K. Tani-K.
Studies on a novel protein complex involved in RNA metabolism during ribosome biogenesis and its regulation by a molecular chaperone
  • 批准号:
    24590101
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    NAGAHAMA Masami
  • 依托单位:
Regulatory mechanism of the ribosomal RNA processing complex by AAA-ATPase NVL2
  • 批准号:
    19570180
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    NAGAHAMA Masami
  • 依托单位:
Functional of nucleolar AAA-ATPase NVL2 in ribosome biogenesis.
  • 批准号:
    17570165
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2005
  • 负责人:
    NAGAHAMA Masami
  • 依托单位:
国内基金
海外基金
C19ORF18通过抑制SEL1L-HRD1 ERAD功能 激活IRE1α在肝脏脂代谢紊乱中的作用 及机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    高荣
  • 依托单位:
去泛素化酶OTUD5在内质网相关蛋白降解(ERAD)中作用的研究
  • 批准号:
    32371313
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    赵文会
  • 依托单位:
基于“正虚伏毒”探究外泌体miRNA-UPR-ERAD/ERSIA通路对肺癌恶病质作用及中药干预研究
  • 批准号:
    2023JJ40486
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    孙银辉
  • 依托单位:
EMC6/ERAD调控肌质网稳态改善心肌肥厚的作用机制
  • 批准号:
    32371242
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    郑铭
  • 依托单位: